AstraZeneca, a global pharmaceutical giant, has chosen Virginia for its largest-ever single manufacturing investment—but officials have yet to say exactly where in the state the facility will be built.
Governor Glenn Youngkin announced the project alongside company CEO Pascal Soriot, calling the multi-billion dollar facility a “cornerstone” of AstraZeneca’s $50 billion U.S. expansion plan. The company says the Virginia facility will be powered by AI, automation, and data analytics, focusing on treatments for cancer, heart and respiratory diseases, and rare conditions.